India's Pharmaceutical Exports

Country Profile

Niger

Niger is an emerging destination for Indian pharmaceutical exports — $64.9M in FY 2025–26, with 4.3× growth over the past decade. Vaccines accounts for 85% of shipments, with vaccines contributing $55.2M. The compound annual growth rate since FY2015 stands at 14.3%.

🇳🇪 $64.9M · 4.3× growth since FY2015 · 14.3% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$64.9M
Exports FY2025–26 DGCIS
4.3×
Growth FY2015→2026
14.3%
CAGR FY2015→2026
85%
Vaccines Share
4
Product Categories Supplied
Niger is an emerging destination for Indian pharmaceutical exports — $64.9M in FY 2025–26, with 4.3× growth over the past decade. Vaccines accounts for 85% of shipments, with vaccines contributing $55.2M. The compound annual growth rate since FY2015 stands at 14.3%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Vaccines $55.2M (85.1%) Medicines $9.60M (14.8%) Surgical & Hospital Supplies $55K (0.1%) Medicine Ingredients $23K (0.0%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Niger in the RBI overseas direct investment dataset (2011–2026).